Ovarian cancer - New drug, GEN-1
Ovarian Cancer – Fast Track Designation to GEN-1 Immunotherapy
Background Women with advanced ovarian cancer have limited treatment options in the standard of care and therefore they have much better chances and hope in fighting their disease with new…